Fluorine-18 chemistry for PET: A concise introduction

Current Radiopharmaceuticals

Volumn 3, Issue 2, 2010, Pages 68-80

  Banister, Samuel ^a   Roeda, Dirk ^b   Dollé, Frédéric ^b   Kassiou, Michael ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3' FLUOROTHYMIDINE F 18; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; FLUOROMETHANE F 18;

ARTICLE; FLUORINATION; ISOTOPE LABELING; MACROMOLECULE; METALLATION; MICROWAVE IRRADIATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOCHEMISTRY; SUBSTITUTION REACTION;

EID: 77954319035     PISSN: 18744710     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874471011003020068     Document Type: Article

References (157)

1. Browne, E.; Dairiki, J.M.; Doebler, R.E. Table of Isotopes. Wiley-Interscience Publishers: New York - Chichester - Brisbane - Toronto, 1978.
2. Qaim, S.M.; Stöcklin, G. Production of some medically importantshort-lived neutron-deficient radioisotopes of halogens. Radiochim.Acta, 1983, 34, 25-40.
3. Welch, M.J.; Redvanly, C.S. Handbook of Radiopharmaceuticals -Radiochemistry and Applications. Wiley: New York - Chichester -Brisbane - Toronto, 2003.
4. Kilbourn, M.R.; Welch, M.J. Fluorine-18 labeled receptor basedradiopharmaceuticals. Appl. Radiat. Isot., 1986, 37, 677-683.
5. Kilbourn, M.R. Fluorine-18 Labeling of Radiopharmaceuticals.National Academy Press: Washington, 1990.
6. Lasne, M.C.; Perrio, C.; Rouden, J.; Barré, L.; Roeda, D.; Dollé, F.; Crouzel, C. Chemistry of β+-Emitting Compounds Based on Fluo-rine-18, in Topics in Current Chemistry. Krause, W., Ed.; Springer-Verlag: Berlin - Heidelberg, 2002, pp. 201-258.
7. Tavitian, B.; Terrazzino, S.; Kühnast, B.; Marzabal, S.; Stettler, O.; Dollé, F.; Deverre, J.-R.; Jobert, A.; Hinnen, F.; Bendriem, B.; Crouzel, C.; DiGiamberardino, L. In vivo imaging of oligonucleo-tides with positron emission tomography. Nat. Med., 1998, 4, 467-471.
8. Okarvi, S.M. Recent progress in fluorine-18-labelled peptide radio-pharmaceuticals. Eur. J. Nucl. Med., 2001, 28, 929-38.
9. Kilbourn, M.R.; Dence, C.S.; Welch, M.J.; Mathias, C.J. Fluorine-18 labeling of proteins. J. Nucl. Med., 1987, 28, 462-470.
10. Wilbur, D.S. Radiohalogenation of proteins: An overview of radi-onuclides, labeling methods and reagents for conjugate labeling.Bioconjug. Chem., 1992, 3, 433-470.
11. Marzabal, S.; Terrazzino, S.; Kühnast, B.; Dollé, F.; Deverre, J.-R.; Jobert, A.; Crouzel, C.; DiGiamberardino, L.; Tavitian, B.vivoimaging and pharmacokinetics of oligonucleotides. NucleosidesNucleotides, 1999, 18, 1731-1733.
12. Younes, C.K.; Boisgard, R.; Tavitian, B. Labelled oligonucleotidesas radiopharmaceuticals: Pitfalls, problems and perspectives. Curr.Pharm. Design, 2002, 8, 1451-1466.
13. Schlyer, D.J. Production of Radionuclides in Accelerators, inHandbook of Radiopharmaceuticals - Radiochemistry and Applications; Welch, M.J.; Redvanly, C.S., Eds.; Wiley: New York -Chichester - Brisbane - Toronto, 2003, pp. 1-70.
14. Ruth, T.J. Accelerators Available for Isotope Production, in Hand-book of Radiopharmaceuticals - Radiochemistry and Applications.Welch, M.J.; Redvanly, C.S., Eds.; Wiley: New York - Chichester -Brisbane - Toronto, 2003, pp. 71-86.
15. Mausner, L.F.; Mirzadeh, S. Reactor Production of Radionuclides,in Handbook of Radiopharmaceuticals - Radiochemistry and Ap-plications; Welch, M.J.; Redvanly, C.S., Eds.; Wiley: New York -Chichester - Brisbane - Toronto, 2003, pp. 86-118.
16. 18F reaction. Radiochim. Acta, 1979, 26, 21-25.
17. Guillaume, M.; Luxen, A.; Nebeling, B.; Argentini, M.; Clark, J.;Pike, V.W. Recommendations for F-18 production. Appl. Radiat.Isot., 1991, 42, 749-762.
18. 2. Appl. Radiat. Isot., 1984, 35, 117-122.
19. 18F. Int. J. Appl. Radiat. Isot., 1968, 19, 27-32.
20. 18F process. Appl.Radiat. Isot., 1986, 37, 1135-1139.
21. 18F-fluorinating in-termediates. Int. J. Appl. Radiat. Isot., 1978, 29, 175-183.
22. 18F-hydrofluoricacid. Int. J. Appl. Radiat. Isot., 1978, 29, 407-408.
23. Clark, J.C.; Oberdorfer, F. Thermal characteristics of the release offluorine-18 from an iconel-600 gas target. J. Label. Compds. Ra-diopharm., 1982, 19, 1337.
24. Helus, F.; Maierborst, W.; Sahm, U.; Wiebe, L.I. F-18 cyclotronproduction methods. Radiochem. Radioanal. Lett., 1979, 38, 395-410.
25. 18F. J. Label. Compds. Radiopharm.,1982, 19, 1620-1622.
26. Clark, J.C.; Goulding, R.W.; Roman, M.; Palmer, A.J. Preparationof fluorine-18-labeled compounds using a recirculatory neon target.Radiochem. Radioanal. Lett., 1973, 14, 101-108.
27. Dahl, J.R.; Lee, R.; Bigler, R.E.; Schmall, B.; Aber, J.E. A newtarget system for the preparation of no-carrier-added F-18 fluori-nated compounds. Int. J. Appl. Radiat. Isot., 1983, 34, 693-700.
28. 18F bydeuteron irradiation of a neon-hydrogen gas-target. Radiochim.Acta, 1983, 33, 49-56.
29. 18F-fluoride in organic solvents: Production and labeling results. J. La-bel. Compds. Radiopharm., 1982, 19, 1639-1640.
30. Berridge, M.S.; Crouzel, C.; Comar, D. Aromatic fluorination withn.c.a. fluoride: A comparative study. J. Label. Compds. Radio-pharm., 1985, 22, 687-694.
31. 18F-labeled diethylaminosulfurtrifluoride. DAST: an F-for-OH fluorinating agent. J. Nucl. Med.,1977, 18, 151-158.
32. 18F radiopharma-ceuticals. J. Chem. Soc., 1981, 81, 198.
33. 18F]perchlorylfluoride. J. Label. Compds. Radiopharm., 2001, 44,S901.
34. Clark, J.H.; Miller, J.M. Hydrogen bonding in organic synthesis. 3. Hydrogen bond assisted reactions of cyclic organic hydrogenbound electron acceptors with halogenoalkanes in presence of po-tassium fluoride. J. Am. Chem. Soc., 1977, 99, 498-504.
35. Clark, J.H. Fluoride-ion as a base in organic synthesis. Chem. Rev.,1980, 80, 429-452.
36. -. J.Label. Compds. Radiopharm., 1983, 20, 501-514.
37. Shiue, C.Y.; Fowler, J.S.; Wolf, A.P.; Watanabe, M.; Arnett, C.D.Syntheses and specific activity determinations of no-carrier-addedfluorine-18-labeled neuroleptic drugs. J. Nucl. Med., 1985, 26, 181-186.
38. 18F-labeled radioligands. J. Label. Compds. Radiopharm., 1986, 23,1038-1039.
39. Shiue, C.Y.; Fowler, J.S.; Wolf, A.P.; McPherson, D.W.; Arnett, C.D.; Zecca, L. No-carrier-added fluorine-18 labeled N-methylspiperidol: synthesis and biodistribution in mice. J. Nucl.Med., 1986, 27, 226-234.
40. 18F]fluoride. Appl. Radiat.Isot., 1988, 39, 699-703.
41. Cox, D.P.; Terpinski, J.; Lawrynowicz, W. Anhydrous tetrabuty-lammonium fluoride - A mild but highly efficient source of nucleo-philic fluoride-ion. J. Org. Chem., 1984, 49, 3216-3219.
42. Sharma, R.K.; Fry, J.L. Instability of anhydrous tetra-normal-alkylammonium fluorides. J. Org. Chem., 1983, 48, 2112-2124.
43. Irie, T.; Fukushi, K.; Ido, T.; Nozaki, T.; Kasida, Y. F-18-labeledfluorination by crown ether metal fluoride. 1. On labeling F-18-21-fluoroprogesterone. Int. J. Appl. Radiat. Isot., 1982, 33, 1449-1452.
44. 18F]-fluoro-2-deoxy-D-glucose us-ing aminopolyether supported nucleophilic substitution. J. Nucl.Med., 1986, 27, 235-238.
45. 18F]fluoroheptadecanoic acid in highyields via aminopolyether supported, nucleophilic fluorination. J.Label. Compds. Radiopharm., 1986, 23, 455-467.
46. Elsinga, P.H. Radiopharmaceutical chemistry for positron emissiontomography. Methods, 2002, 27, 208-217.
47. 18F: Labeling Chemistry and Labeled Compounds, in Handbook of Nuclear Chemistry; Vertes, A., Ed.; Kluwer Aca-demic Publishers: Dordrecht, 2003, pp. 167-209.
48. Ferrieri, R.A. Production and Application of Synthetic PrecursorsLabeled with Carbon-11 and Fluorine-18; Wiley: Chichester,2003.
49. Snyder, S.E.; Kilbourn, M.R. Chemistry of Fluorine-18 Radio-pharmaceuticals, in Handbook of Radiopharmaceuticals - Radio-chemistry and Applications; Welch, M.J.; Redvanly, C.S., Eds.;Wiley: New York - Chichester - Brisbane - Toronto, 2003, pp. 195-228.
50. Rozen, S. Elemental fluorine as a legitimate reagent for selectivefluorination of organic compounds. Acco. Chem. Res., 1988, 21,307-312.
51. Wilkinson, J.A. Recent advances in the selective formation of theC-F bond. Chem. Rev., 1992, 92, 505-519.
52. 18F-radiopharmaceu-ticals. Appl. Radiat. Isot., 1986, 37, 685-694.
53. 18F labeled elemental fluorine for radiophar-maceutical preparation. J. Nucl. Med., 1980, 21, 750-757.
54. 2 production using the neon/fluorine target. J. Nucl. Med., 1980, 21, 758-762.
55. Chambers, R.D.; Skinner, C.J.; Hutchinson, J.; Thomson, J. Ele-mental fluorine. 1. Synthesis of fluoroaromatic compounds. J.Chem. Soc. Perkin Trans., 1966, 1, 605-609.
56. Moilliet, J.S. The use of elemental fluorine for selective directfluorinations. J. Fluor. Chem., 2001, 109, 13-17.
57. 18F-fluorinatingintermediate - trifluoromethyl hypofluorite. Int. J. Appl. Radiat.Isot., 1978, 29, 323-327.
58. 18F-labeled acetyl hypofluo-rite. J. Nucl. Med., 1982, 23, 899-903.
59. 18F-2-fluoro-2-deoxy-D-glucose. Nuklearmedizin, 1982. 121 (Suppl), 823-825.
60. Ehrenkaufer, R.E.; Potocki, J.F.; Jewett, D.M. Simple synthesis of F-18-labeled 2-fluoro-2-deoxy-D-glucose. J. Nucl. Med., 1984, 25,333-337.
61. 18F]-perchlorylfluoride and its reactions with functionalized aryllithiums. Int. J.Appl. Radiat. Isot., 1983, 34, 613-615.
62. 18F]fluorine gas.Int. J. Appl. Radiat. Isot., 1984, 35, 401-404.
63. 18F]fluoro-2-pyridone. Appl. Ra-diat. Isot., 1988, 39, 685-688.
64. 18F-labeled N-fluoropyridinium triflate. J. Label. Compds. Radio-pharm., 1988, 25, 999-1005.
65. 18F]fluoro-N-alkylsulfonamides: Novel reagents formild and regioselective radiofluorination. Appl. Radiat. Isot., 1990,41, 733-738.
66. 14C-2-deoxy-2-fluoro-D-glucose. J. Label. Compds. Radiopharm., 1978,14, 175-183.
67. 18F-5-fluorouracil. J. Nucl. Med., 1973, 14, 63-64.
68. 18F-5-fluorouracil. Int. J. Appl. Radiat. Isot., 1979, 30,401-405.
69. 18F-labelled 5-fluorouracil using acetylhy-pofluorite. Nucl. Med. Biol., 1984, 11, 141-142.
70. 18F-labelled 5-fluorouracil of very high purity. J. Label. Compds. Ra-diopharm., 1989, 27, 137-145.
71. 18F-fluorouridine and related compounds as probe for measuring tissueproliferation vivo. J. Label. Compds. Radiopharm., 1984, 21,865-873.
72. 18F]fluoro-2'-deoxyuridine. J. Label. Compds. Radiopharm.,1984, 21, 1231-1233.
73. 18F]fluoro-2'-deoxyuridine. Appl. Radiat. Isot., 1987, 38, 467-473.
74. 18F]-fluorouridine as a probe for measuring tissue proliferation invivo. J. Label. Compds. Radiopharm., 1982, 19, 1395.
75. 18F-labelled cytosine- anduracil-nucleosides. Appl. Radiat. Isot., 1986, 37, 1074-1076.
76. 18F]fluoro-L-DOPA. J. Nucl. Med.,1984, 25, 1228-1233.
77. Coenen, H.H.; Franken, K.; Kling, P.; Stöcklin, G. Direct electro-philic radiofluorination of phenylalanine, tyrosine and DOPA. Appl. Radiat. Isot., 1988, 39, 1243-1250.
78. Coenen, H.H.; Moerlein, S.M. Regiospecific aromatic fluorode-metallation of group IVb metalloarenes using elemental fluorine oracetyl hypofluorite. J. Fluor. Chem., 1987, 36, 63-75.
79. 18F]Fluoro-L-DOPA by radiofluorodestannylation:A short and simple synthesis of a new labelling precursor. J. Label.Compds. Radiopharm., 1998, 41, 105-114.
80. 18F]fluoro-L-DOPA. Appl. Radiat. Isot.,1999, 51, 389-394.
81. 18F]fluoro-L-DOPApreparation: Precursor synthesis, preparative HPLC purificationand determination of radiochemical purity. Nucl. Med. Biol., 2002,29, 477-481.
82. 18F]fluoro-L-DOPA. Appl.Radiat. Isot., 1992, 43, 989-996.
83. 18F]fluoropropyl)-2,3-dimethoxybenzamide asan improved dopamine D-2 receptor tracer. Nucl. Med. Biol., 1995,22, 283-296.
84. 18F-fluorination of 1,N-disubstituted alkanes as fluoroalkylation agents. J. Label. Compds. Radiopharm., 1987, 24, 1029-1042.
85. 18F]Fluoroalkyl agents: Synthesis, reac-tivity and application for development of PET ligands in molecularimaging. Curr. Top. Med. Chem., 2007, 7, 1817-1828.
86. 18F-labeled choline as an oncologic tracer for positronemission tomography: initial findings in prostate cancer. CancerRes., 2001, 61, 110-117.
87. 18FDG), in Handbook of Radiopharmaceu-ticals - Radiochemistry and Applications; Welch, M.J.; Redvanly,C.S., Eds; Wiley: New York - Chichester - Brisbane - Toronto,2003, pp. 307-322.
88. 18F]FDG using an alkaline hydrolysis on solidsupport. J. Label. Compds. Radiopharm., 1999, 42, S515-516.
89. 18F]FDG produced by analkaline hydrolysis on solid support under stringent conditions. Appl. Radiat. Isot., 2002, 56, 871-875.
90. 18F]FDG synthesisby alkaline hydrolysis on a low polarity solid phase support. J. La-bel. Compds. Radiopharm., 2002, 45, 435-437.
91. Lee, C.C.; Sui, G.; Elizarov, A.; Shu, C.J.; Shin, Y.S.; Dooley, A.N.; Huang, J.; Daridon, A.; Wyatt, P.; Stout, D.; Kolb, H.C.; Witte, O.N.; Satyamurthy, N.; Heath, J.R.; Phelps, M.E.; Quake, S.R.; Tseng, H.R. Multistep synthesis of a radiolabeled imagingprobe using integrated microfluidics. Science, 2005, 310, 1793-1796.
92. Gillies, J.M.; Prenant, C.; Chimon, G.N.; Smethurst, G.J.; Perrie, W.; Hambletta, I.; Dekker, B.; Zweit, J. Microfluidic reactor for theradiosynthesis of PET radiotracers. Appl. Radiat. Isot., 2006, 64,325-332.
93. 18F]FLT). J. Radioanal. Nucl.Chem., 2000, 243, 843-846.
94. 18F]fluoro-thymidinewith 2,3'-anhydro-5'-O-(4,4'-dimethoxytrityl)thymidine. J. Label.Compds. Radiopharm., 2000, 43, 1211-1218.
95. 18F]fluorothymidine usingthree precursors. Appl. Radiat. Isot., 2006, 64, 187-193.
96. Kämäräinen, E.L.; Kyllonen, T.; Nihtilä, O.; Björk, H.; Solin, O. Preparation of fluorine-18-labeled fluoromisonidazole using twodifferent synthesis methods. J. Label. Compds. Radiopharm., 2004,47, 37-45.
97. 18F]fluoro-L-proline, radiotracers for PET-investigation of disordered matrixprotein synthesis. J. Label. Compds. Radiopharm., 1999, 42, 1135-1144.
98. 18F]fluoroethyl)-L-tyrosine. Appl.Radiat. Isot., 2002, 57, 853-856.
99. 18F]FLT preparation. J. Radioanal. Nucl. Chem., 2002, 251, 55-58.
100. van Dort, M.E.; Jung, Y.W.; Sherman, P.S.; Kilbourn, M.R.;Wie-land, D.M. Fluorine for hydroxy substitution in biogenic amines:Asymmetric synthesis and biological evaluation of fluorine-18-labeled beta-fluorophenylalkylamines as model systems. J. Med.Chem., 1995, 38, 810-815.
101. 18F]fluoro-2-methyl-2-(methylamino)-propanoic acid. J. Med. Chem., 2002, 45, 2240-2249.
102. 18F-labeleddifluoroestradiols: Preparation and preclinical evaluation as estro-gen receptor-binding radiopharmaceuticals. Steroids, 2002, 67,765-775.
103. 18F]fluorine substitution at the 16- -position of fulvestrant. Nucl. Med. Biol., 2004, 31, 691-698.
104. 18F]fluoro-L-ascorbic acid. Appl. Radiat. Isot., 1992, 43, 633-639.
105. O'Hagan, D.; Schaffrath, C.; Cobb, S.L.; Hamilton, J.T.G.; Mur-phy, C.D. Biosynthesis of an organofluorine molecule. Nature,2002, 416, 279.
106. Martarello, L.; Schaffrath, C.; Deng, H.; Gee, A.D.; Lockhart, A.; O'Hagan, D. The first enzymatic method for C-F-18 bond forma-tion: The synthesis of 5'-[F-18]-fluoro-5'-deoxyadenosine for imag-ing with PET. J. Label. Compds. Radiopharm., 2003, 46, 1181-1189.
107. Deng, H.; Cobb, S.L.; Gee, A.D.; Lockhart, A.; Martarello, L.; McGlinchey, R.P.; O'Hagan, D.; Onega, M. Fluorinase mediated C-F-18 bond formation, an enzymatic tool for PET labelling. Chem.Commun., 2006, 652-654.
108. Smith, M.B.; March, J. March's Advanced Organic Chemistry -Reactions, Mechanisms, and Structure; 5th ed. Wiley-Interscience:New York - Chichester - Brisbane - Toronto, 2001.
109. Angelini, G.; Speranza, M.; Wolf, A.P.; Shiue, C.Y. Nucleophilicaromatic-substitution of activated cationic groups by F-18-labeledfluoride - A useful route to no-carrier-added (nca) F-18-labeled arylfluorides. J. Fluor. Chem., 1985, 27, 177-191.
110. Haka, M.S.; Kilbourn, M.R.;Watkins, L.; Toorongian, S.A. Aryl-trimethylammonium trifluoromethanesulfonates as precursors toaryl [F-18] fluorides - Improved synthesis of [F-18]GBR-13119. J.Label. Compds. Radiopharm., 1989, 27, 823-833.
111. Dollé, F. Fluorine-18-labelled fluoropyridines: Advances in radio-pharmaceutical design. Curr. Pharm. Design., 2005, 11, 3221-3235.
112. Stone-Elander, S.; Elander, N. Microwave applications in radiola-belling with short-lived positron-emitting radionuclides. J. Label.Compds. Radiopharm., 2002, 45, 715-746.
113. Stone-Elander, S.; Elander, N. Microwave cavities: Some parame-ters affecting their use in radiolabeling reactions. Appl. Radiat.Isot., 1991, 42, 885-887.
114. Elander, N.; Jones, J.R.; Lu, S.Y.; Stone-Elander, S. Microwave-enhanced radiochemistry. Chem. Soc. Rev., 2000, 29, 239-249.
115. Hwang, D.R.; Moerlein, S.M.; Lang, L.; Welch, M.J. Applicationof microwave technology to the synthesis of short-lived radiophar-maceuticals. J. Chem. Soc. Chem. Commun., 1987, 1799-1801.
116. Lemaire, C.; Cantineau, R.; Guillaume, M.; Plenevaux, A.; Christi-aens, L. Fluorine-18-altanserin: A radioligand for the study of sero-tonin receptors with PET: Radiolabeling and in vivo biologic be-havior in rats. J. Nucl. Med., 1991, 32, 2266-2272.
117. 18F]altanserin. Appl. Radiat. Isot., 1999, 50, 923-927.
118. 2H dual-labeled altanserin, a metabolically re-sistant PET ligand for 5-HT2A receptors. J. Label. Compds. Radio-pharm., 1999, 42, 457-467.
119. 18F]Setoperone. J. Label.Compds. Radiopharm., 1988, 25, 403-414.
120. Hamacher, K.; Hamkens, W. Remote-controlled one-step produc-tion of F-18 labeled butyrophenone neuroleptics exemplified by thesynthesis of nca [F-18]N-methylspiperone. Appl. Radiat. Isot.,1995, 46, 911-916.
121. 18F]MPPF, a fluoro analog ofWAY-100635. Nucl. Med. Biol., 1998, 25, 343-350.
122. 18F]fluoride. J. Label. Compds. Radiopharm., 2005, 48, S145.
123. -. J. Org. Chem.,1999, 64, 178-185.
124. 18F]fluoro-L-DOPA using 3,5,7,8,8a-hexahydro-7,7,8a-trimethyl-[6S-(6, 8, 8)]-6,8-methano-2H-1,4-benzoxazin-2-one. J. Label. Compds. Radiopharm., 1995, 36, 409-423.
125. 18F]fluorodopa via NCA nucleophilic fluorination. Appl. Radiat.Isot., 1991, 42, 629-635.
126. 18F]fluoro-L-dopa via two chiral auxiliaries. Appl. Radiat. Isot.,1993, 44, 737-744.
127. Damhaut, P.; Lemaire, C.; Plevenaux, A.; Brihaye, C.; Christiaens, L.; Comar, D. No-carrier-added asymmetric synthesis of -methyl-amino acids labeled with fluorine-18. Tetrahedron, 1997, 53,5785-5796.
128. Corey, E.J.; Xu, F.; Noe, M.C.; Mark, C. A rational approach tocatalytic enantioselective enolate alkylation using a structurally ri-gidified and defined chiral quaternary ammonium salt under phasetransfer conditions. J. Am. Chem. Soc., 1997, 119, 12414-12415.
129. Corey, E.J.; Noe, M.C.; Xu, F. Highly enantioselective synthesis ofcyclic and functionalized alpha-amino acids by means of a chiralphase transfer catalyst. Tetrahedron Lett., 1998, 39, 5347-5350.
130. 18F]fluoro-L-DOPA by chiral phase-transfer alkylation. Eur. J.Org. Chem., 2004, 13, 2899-904.
131. Joule, J.A.; Mills, K. Heterocyclic Chemistry. 4th ed. BlackwellScience: Oxford - London - Edinburgh - Malden - Paris - Berlin -Tokyo, 2000.
132. 18F]fluoronicotine. Int. J.Appl. Radiat. Isot., 1984, 35, 1125-1128.
133. 18F]Fluoro-5-pyridyl)-7-azabicyclo[2.2.1]heptane. J. La-bel. Compds. Radiopharm., 1996, 28, 355-365.
134. Horti, A.G.; Scheffel, U.; Stathis, M.; Finley, P.; Ravert, H.T.; London, E.D.; Dannals, R.F. Fluorine-18-FPH for PET imaging ofnicotinic acetylcholine receptors. J. Nucl. Med., 1996, 38, 1260-1265.
135. Villemagne, V.L.; Horti, A.G.; Scheffel, U.; Ravert, H.T.; Finley, P.; Clough, D.J.; London, E.D.; Wagner, H.N.; Dannals, R.F. Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epi-batidine analog. J. Nucl. Med., 1997, 38, 1737-1741.
136. Ding, Y.S.; Gatley, J.; Fowler, J.S.; Volkow, N.D.; Aggarwal, D.; Logan, J.; Dewey, S.L.; Liang, F.; Carroll, F.I.; Kuhar, M.J. Map-ping nicotinic acetylcholine receptors with PET. Synapse, 1996, 24,403-407.
137. 18F]norchlorofluoroepibatidine and its N-methyl deriva-tive: New PET ligands for mapping nicotinic acetylcholine recep-tors. J. Label. Compds. Radiopharm., 1997, 39, 828-832.
138. Liang, F.; Navarro, H.A.; Abraham, P.; Kotian, P.; Ding, Y.S.; Fowler, J.S.; Volkow, N.D.; Kuhar, M.J.; Carroll, F.I. Synthesisand nicotinic acetylcholine receptor binding properties of exo-2-(2'-fluoro-5'-pyridinyl)-7-azabicyclo-[2.2.1]heptane: A new positronemission tomography ligand for nicotinic receptors. J. Med. Chem.,1997, 40, 2293-2295.
139. 18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine, a highly potent radioligand for in vivoimaging central nicotinic acetylcholine receptors. J. Label.Compds. Radiopharm., 1998, 41, 451-463.
140. Dollé, F.; Dolci, L.; Valette, H.; Hinnen, F.; Vaufrey, F.; Guenther, I.; Fuseau, C.; Coulon, C.; Bottlaender, M.; Crouzel, C. Synthesisand nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: A new positron emis-sion tomography ligand for nicotinic receptors. J. Med. Chem.,1999, 42, 2251-2259.
141. 18F]F-A-85380). J. Label. Compds.Radiopharm., 1998, 41, 309-318.
142. Tavitian, B. In vivo imaging with oligonucleotides for diagnosisand drug development. Gut, 2003, 52, 40-47.
143. Tavitian, B. Oligonucleotides as radiopharmaceuticals, in Molecu-lar Imaging. Ernst Schering Research Foundation Workshop 49;Bogdanov, A.A.; Licha, K., Eds.; Springer-Verlag: Berlin - Heidel-berg - New York, 2004, pp. 1-34.
144. Wester, H.J.; Hamacher, K.; Stöcklin, G. A comparative study of N.C.A. fluorine-18 labeling of proteins via acylation and photoac-tivation. Nucl. Med. Biol., 1996, 23, 365-372.
145. 18F]fluorobenzoate. Nucl. Med.Biol., 1992, 19, 275-281.
146. 18F]fluorobenzoate and its application to the label-ing of monoclonal antibody fragment. Bioconjug. Chem., 1994, 5,352-356.
147. 18F-labeled in-sulin: A prosthetic group methodology for incorporation of a posi-tron emitter into peptides and proteins. Biochemistry, 1989, 28,4801-4806.
148. 18F for invivo PET imaging. J. Label. Compds. Radiopharm., 1997, 39, 319-330.
149. Kuhnast, B.; Dollé, F.; Terrazzino, S.; Rousseau, B.; Loc'h, C.; Vaufrey, F.; Hinnen, F.; Doignon, I.; Pillon, F.; David, C.; Crouzel, C.; Tavitian, B. A general method to label antisense oligonucleo-tides with radioactive halogens for pharmacological and imagingstudies. Bioconjug. Chem., 2000, 11, 627-636.
150. 18F]fluoropyridine-basedmaleimide reagent for the labeling of peptides and proteins. Bio-conjug. Chem., 2005, 16, 406-420.
151. 18F-fluorobenzamido)ethyl]maleimide, and Synthesis of RGD peptide-based tracer for PET imaging of alpha-v-beta-3-integrin expression. J. Nucl. Med., 2006, 47, 1172-1180.
152. Poethko, T.; Schottelius, M.; Thumshirn, G.; Herz, M.; Haubner, R.; Henriksen, G.; Kessler, H.; Schwaiger, M.; Wester, H.J. Che-moselective pre-conjugate radiohalogenation of unprotected mono-and multimeric peptides via oxime formation. Radiochim. Acta,2004, 4-6, 317-327.
153. Poethko, T.; Schottelius, M.; Thumshirn, G.; Hersel, U.; Herz, M.; Henriksen, G.; Kessler, H.; Schwaiger, M.; Wester, H.J. Two-stepmethodology for high-yield routine radiohalogenation of peptides:18 F-labeled RGD and octreotide analogs. J. Nucl. Med., 2004, 45,892-902.
154. 18F]fluoropeptides using CuI catalyzed 1,3-dipolar cycloaddition.Tetrahedron Lett., 2006, 47, 6681-6684.
155. 18Flabeling of bioactive peptides. J. Label. Compds. Radiopharm.,2008, 51, 444-452.
156. 18F]FPyKYNE, afluoropyridine-based alkyne reagent designed for fluorine-18 label-ling of macromolecules using click chemistry. J. Label. Compds.Radiopharm., 2008, 51, 336-342.
157. 18F]Fluoroethyl-azide for Positron Emission Tomography. Bioconjug. Chem., 2007,18, 989-993.